ArticleChem catalysis2025
Performance-enhancing asymmetric catalysis unlocks tuning without rebuilding.
Article in Chem catalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Performance-Enhancing Asymmetric Catalysis (PEAC) is a new strategy for catalyst optimization. Rather than relying on the slow, resource- and time-intensive covalent modification of chiral ligands, this approach "tunes" a single ligand using a library of simple, achiral acids. The counterions produced upon ion pair formation perturbate the catalyst's chiral pocket through non-covalent interactions to significantly improve enantioselectivity. This method creates an adaptable chiral ligand system that is well-suited for rapid, high-throughput screening and catalyst discovery.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.